Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Director/PDMR Shareholding

22 Sep 2020 15:59

RNS Number : 7716Z
Polypipe Group PLC
22 September 2020
 

Polypipe Group plc (the "Company")

Notification of transactions by Person Discharging Managerial Responsibilities

The Company announces that on 16 September 2020, Paul James, Chief Financial Officer and a Person Discharging Managerial Responsibilities, exercised a nil-cost option over 30,755 ordinary shares of £0.001 each in the capital of the Company ('Shares') in accordance with the Deferred Share Award that was granted to him on 21 March 2018.

Full details of the Award were included in a regulatory announcement released on 21 March 2018 and in the Company's 2017 Annual Report and Accounts. The Company's Employee Benefit Trust has today transferred 16,300 Shares to Mr James which represents the net number of Shares due to him after the appropriate tax and national insurance liabilities were taken into account.

The notification below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul James

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options comprised in the Deferred Share Award ("DSA") granted on 21 March 2018

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

16,300 - Number of DSA Shares acquired after reduction for appropriate tax and national insurance liabilities.

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

22 September 2020

f)

 

Place of the transaction

 

 

Outside a trading venue

 

Enquiries:

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKBBPQBKDFCB
Date   Source Headline
31st Jul 20185:18 pmRNSTotal Voting Rights
10th Jul 20181:20 pmRNSHolding(s) in Company
29th Jun 20189:25 amRNSHolding(s) in Company
28th Jun 20189:14 amRNSHolding(s) in Company
18th Jun 20182:50 pmRNSHolding(s) in Company
13th Jun 20184:02 pmRNSHolding(s) in Company
13th Jun 20189:56 amRNSHolding(s) in Company
8th Jun 201810:22 amRNSDirector appointment
1st Jun 20189:00 amRNSTotal Voting Rights
24th May 20184:27 pmRNSDirector/PDMR Shareholding
23rd May 201812:28 pmRNSResult of AGM
23rd May 20187:00 amRNSTrading Update
17th May 201812:27 pmRNSHolding(s) in Company
9th May 20187:00 amRNSCapital Markets Day
2nd May 20184:14 pmRNSDirector/PDMR Shareholding
2nd May 20183:22 pmRNSDirector/PDMR Shareholding
1st May 201811:04 amRNSTotal Voting Rights
19th Apr 201812:00 pmRNSAnnual Financial Report
4th Apr 20187:00 amRNSDirector/PDMR Shareholding
3rd Apr 201812:49 pmRNSTotal Voting Rights
29th Mar 20181:24 pmRNSCompletion of Disposal
21st Mar 20181:50 pmRNSDirector/PDMR Shareholding
20th Mar 20187:00 amRNSFinal Results
1st Mar 201810:34 amRNSTotal Voting Rights
14th Feb 20189:47 amRNSHolding(s) in Company
12th Feb 20181:30 pmRNSHolding(s) in Company
5th Feb 20181:34 pmRNSHolding(s) in Company
1st Feb 20183:24 pmRNSHolding(s) in Company
1st Feb 20181:38 pmRNSTotal Voting Rights
31st Jan 20187:00 amRNSPotential sale of French operations/trading update
26th Jan 201810:00 amRNSDirector Appointment
24th Jan 20184:04 pmRNSHolding(s) in Company
3rd Jan 20184:47 pmRNSTotal Voting Rights
14th Dec 20179:47 amRNSHolding(s) in Company
13th Dec 20172:01 pmRNSHolding(s) in Company
7th Dec 20179:31 amRNSHolding(s) in Company
5th Dec 20173:21 pmRNSHolding(s) in Company
1st Dec 201710:09 amRNSTotal Voting Rights
28th Nov 20172:52 pmRNSDirector Declaration
14th Nov 20177:00 amRNSTrading Update
1st Nov 201712:49 pmRNSDirector/PDMR Shareholding
27th Oct 201712:17 pmRNSHolding(s) in Company
18th Oct 20174:20 pmRNSHolding(s) in Company
12th Oct 20171:07 pmRNSHolding(s) in Company
10th Oct 201710:37 amRNSHolding(s) in Company
2nd Oct 20174:08 pmRNSTotal Voting Rights
27th Sep 20174:52 pmRNSDirector appointment
15th Sep 201712:04 pmRNSHolding(s) in Company
7th Sep 20174:53 pmRNSDirector/PDMR Shareholding
1st Sep 201712:03 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.